Contract 75H71024F80289
Mckesson Corporation · Department Of Health And Human Services · July 11, 2024
Mckesson Corporation was awarded a federal contract by Department Of Health And Human Services (Indian Health Service) on July 11, 2024 for $11.67 million of work in pharmaceutical preparation manufacturing. Performance is in Irving, TX. This is a task or delivery order issued under parent IDIQ 36W79720D0001. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 18, 2026. If all options are exercised, the contract could reach $26.67 million.
Contract details
- PIID
- 75H71024F80289
- Parent IDIQ
- 36W79720D0001
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Irving, TX
- First action
- July 11, 2024
- Latest action
- March 18, 2026
Description
MOD 4 - DEOBLIGATE CLIN 4
Modification timeline
-
March 18, 2026Mod P00004 · Close Out$26.67M
-
August 19, 2024Mod P00001 · Exercise An OptionMOD 1 - EXERCISE OPTION 1 - 24-GIMC-CLINICAL-PHARMACY-SUPPLIES-PRIME VENDOR CONTRACT MCKESSON CORP- PERIOD OF PERFORMANCE 8/10/2024-7/31/2024$15.00M
-
July 11, 2024Base award24-GIMC-CLINICAL-PHARMACY-SUPPLIES-PRIME VENDOR CONTRACT MCKESSON CORP- PERIOD OF PERFORMANCE 8/10/2024-7/31/2024$26.67M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75H71024F80289?
Contract 75H71024F80289 is a federal contract awarded to Mckesson Corporation by Department Of Health And Human Services on July 11, 2024 for $11.67 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75H71024F80289?
Mckesson Corporation won contract 75H71024F80289 from Department Of Health And Human Services.
How much is contract 75H71024F80289 worth?
Contract 75H71024F80289 has obligated $11.67 million to date, with a total potential value of $26.67 million if all options are exercised.